CISD2 and hepatocellular carcinoma: In summary, the inhibition of CISD2 promotes Beclin1 action, facilitates autophagy that occurs in HCC cells resistant to sorafenib, and increases the intracellular iron concentration (Li et al., 2021) (Figure 3).